- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-59/18: Judgment of the General Court of 22 November 2018 — Endoceutics v EUIPO — Merck (FEMIVIA) (EU trade mark — Opposition proceedings — Application for EU word mark FEMIVIA — Earlier EU word mark FEMIBION INTIMA — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EU) 2017/1001)
ECLI:EU:UNKNOWN:62018TA0059
62018TA0059
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
4.2.2019
Official Journal of the European Union
C 44/46
(Case T-59/18) (*)
((EU trade mark - Opposition proceedings - Application for EU word mark FEMIVIA - Earlier EU word mark FEMIBION INTIMA - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001))
(2019/C 44/58)
Language of the case: English
Parties
Applicant: Endoceutics, Inc. (Quebec, Canada) (represented by: M. Wahlin, lawyer)
Defendant: European Union Intellectual Property Office (represented by: A. Lukošiūtė, acting as Agent)
Other party to the proceedings before the Board of Appeal of EUIPO: Merck KGaA (Darmstadt, Germany)
Re:
Action brought against the decision of the Second Board of Appeal of EUIPO of 27 November 2017 (Case R 280/2017-2), relating to opposition proceedings between Merck and Endoceutics.
Operative part of the judgment
The Court:
1.Dismisses the action;
2.Orders Endoceutics, Inc. to pay the costs.
(*) Language of the case: English.
(1) OJ C 112, 26.3.2018.